TMCnet News

Aug 6 OTCBB Penny Stock News - VYTR, INSV, WPUR, VRYAF
[August 06, 2010]

Aug 6 OTCBB Penny Stock News - VYTR, INSV, WPUR, VRYAF


(M2 PressWIRE Via Acquire Media NewsEdge) Stocksource.us brings you all the Stocks in the News: Vyteris Inc. (OTCBB: VYTR), InSite Vision Incorporated (OTCBB:INSV), WaterPure International Inc. (OTCBB:WPUR), ViryaNet Limited (VRYAF.OB) Receive all the news and alerts first. Sign up for the news letter :http://www.stocksource.us For stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny_stock Vyteris Inc. (OTCBB: VYTR) LOS ANGELES, CA -- 08/05/10 -- Two weeks ago, Vyteris, Inc. (OTCBB: VYTR), the manufacturer of the first FDA-approved active patch transdermal drug delivery system announced the appointment of four new members to its Scientific Advisory Board. The news went mostly unnoticed, but it could point to some significant catalysts and developments for a company that recently found itself on the ropes.



BioMedReports.Com, the news portal which covers Wall Street's biomedical sector, has issued a trade alert for Vyteris after reporting that finance industry sources have indicated that Phase 2 data for the company's innovative product to treat female infertility "is very strong" and that the company is close to signing a deal worth $20 million upfront which is also loaded with not only milestones, but also royalties.

VYTR had previously partnered with Ferring Pharmaceuticals to develop the product which would mimic the female body's natural rhythms of hormonal secretions. The product would make it possible to administer a peptide without needles, and was being designed to deliver multiple transdermal pulses automatically, around the clock with as little as two 12-hour patches per day. In addition to the less painful therapy, there were also potential benefits that would possibly reduce the likelihood of multiple births.


However, in December of 2009, Vyteris received notice from Ferring that they were terminating a License and Development Agreement, dated September 30, 2004. This rocked the stability of the company and shares saw a rocky ride from highs of $1.40 to lows of $.11.

The company has approximately 65 million outstanding shares, but only about 5 million are currently in the float. Since the rest are tightly held, the stock may be poised to climb higher on news.

Follow our news and alerts with our newsletter sign up today: http://www.stocksource.us *************************************************************************************** InSite Vision Incorporated (OTCBB:INSV) ALAMEDA, Calif.--(Aug 6)-- InSite Vision Incorporated (OTCBB:INSV) today reported operating and financial results for the quarter ended June 30, 2010.

Pipeline Updates * In June 2010, InSite Vision filed an Investigational New Drug application (IND) for a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory and pain product candidate that combines a low concentration of bromfenac in DuraSite. InSite Vision is developing ISV-303 to reduce the pain and swelling associated with ocular surgery and plans to initiate the Phase 1/2 clinical trial in the third quarter of 2010.

* InSite Vision is working with the U.S. Food and Drug Administration (FDA) to obtain a Special Protocol Assessment (SPA) for the Phase 3 development program of ISV-502 and ISV-305, two novel products based on the company's proprietary DuraSite technology. ISV-502 (a combination of azithromycin and dexamethasone in DuraSite) and ISV-305 (dexamethasone in DuraSite) are both being developed for the treatment of blepharitis, an ocular disease characterized by inflammation of the eyelids.

"We are committed to building value in our pipeline programs and the second quarter 2010 reflects continued progress in our efforts," said Louis Drapeau, InSite Vision's Chief Executive Officer. "A clinical trial for ISV-303 is set to begin shortly. At the same time, we are making important strides in the planning of a Phase 3 clinical program for ISV-502 and ISV-305 for blepharitis, and believe that our approach in working closely with the FDA will enable us to reduce risks while efficiently obtaining efficacy data on two products." Sign up for our newsletter: http://www.stocksource.us ******************************************************************************** WaterPure International Inc. (OTCBB:WPUR) OAKLAND PARK, Fla.--(Aug 6)-- WaterPure International Inc. (OTCBB:WPUR) announces the appointment of Brian Lappin, Aquamagic, County Armagh, Ireland as the exclusive distributor for their WaterCycle Atmospheric Water Generator (AWG) in Great Britain and Ireland. The distributor agreement requires a minimum order of 200 units over 24 months which are expected to be sold to schools, factories, government offices, hospitals, homes, and offices.

"As drought situations prevail in many parts of the Isles, we are excited to place our WaterCycle AWG with a distributor in the area and offer a solution to the problem. For less than 10 cents per gallon, our unique WaterCycle AWG can generate 7-12 gallons of 100% carcinogen-free pure water a day. It should be a win/win for all; truly a great marketplace for our WaterCycle AWG," states Paul Lipschutz, Chairman, WaterPure International, Inc.

Follow our news and alerts with our newsletter sign up today: http://www.stocksource.us *************************************************************************************** ViryaNet Limited (VRYAF.OB) SOUTHBOROUGH, Mass.--(Aug 5)-- ViryaNet Limited (VRYAF.OB), a leading provider of mobile workforce management solutions that optimize the full cycle of scheduling and dispatch processes for field service management announced 3 recent wins through 3 different ViryaNet channel partners.

The first partner success occurred in the UK division of a global food and beverage company. The ViryaNet field service solution, will be deployed by its partner in a hosted environment, and will provide both mobile workforce management and supply chain management functionality. The solution will enable the customer's technicians to report job status, order parts, update customer records, and access detailed site information as well performing critical on-site maintenance. By optimizing scheduling, and automating field service processes, the customer is able to respond more quickly with technicians who are better equipped to complete the job. The result is that millions of people across the UK will enjoy an uninterrupted flow of one of their most beloved brands.

In the case of the Midwestern utility which provides energy delivery services to over a million customers, ViryaNet's partner will consolidate their customer's field service scheduling and optimization processes onto a rebranded version of the ViryaNet G4 mobile workforce management solution. The customer scheduling operations have historically been divided into 3 silos, service, construction and outage, each with its own work orders and its own method of optimizing and scheduling those orders.

Finally, a water utility which ensures the treatment, delivery and availability of high-quality drinking water in America's Southwest found a novel solution to their needs for scheduling and dispatch without investing in a dispatch center. The utility outsourced their dispatch operation to the ViryaNet channel partner who, in turn, deployed a dispatch center and equipped the customer with a mobility solution, both powered by ViryaNet.

"3 recent wins from 3 different partners is exactly the pace of new business activity we have positioned ourselves for," remarked Memy Ish Shalom, CEO of ViryaNet, "but perhaps more importantly" he continued, "it once again validates our core business plan of growth through multiple, diversified, channel partners" Sign up for our newsletter: http://www.stocksource.us ************************************************************************************** For A Comprehensive Coverage of Stock Please Visit: http://www.stocksource.us E-mail: [email protected] | Phone number: +1 866 807 4021 For stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny_stock StockSource.us offers a newsletter covering companies traded on the OTC, OTCBB, PINKSHEETS and AMEX stock exchanges. Subscribers to our newsletter will receive up to date time sensitive press releases and profiles on featured companies traded on various small cap stock exchanges such as otc, otcbb, pinksheet and amex. Other sectors we cover are: alternative energy stocks/companies (solar stocks, wind stocks, hydro stocks, nuclear stocks, uranium stocks, biofuel stocks, clean coal stocks) as well as oil and gas stocks, gold stocks and mining stocks.

Iron Consulting Inc. delivers a broad spectrum of services designed to meet your goals and fit your budget. They include: Search Engine Optimization, Email Campaigns, Financial News Distribution and Media Exposure, CEO Interviews, Analyst Reports, Investment Opinion Services, Web Design and Development, Audio & Video Profiles and Shareholder Communications.

StockSource.us is owned and operated by Iron Consulting.

Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), StockSource.us is owned and operated by Iron Consulting. Iron Consulting has not been compensated for this article. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

(n) 2006 StockSource.us All Rights Reserved. Disclaimer E-mail: [email protected] Phone number: +1 866 807 4021 ((Comments on this story may be sent to [email protected])) (c) 2010 M2 COMMUNICATIONS

[ Back To TMCnet.com's Homepage ]